Holocene Advisors, LP Eli Lilly & CO Transaction History
Holocene Advisors, LP
- $29.2 Billion
- Q4 2024
A detailed history of Holocene Advisors, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Holocene Advisors, LP holds 426,314 shares of LLY stock, worth $392 Million. This represents 1.13% of its overall portfolio holdings.
Number of Shares
426,314
Previous 437,603
2.58%
Holding current value
$392 Million
Previous $388 Million
15.11%
% of portfolio
1.13%
Previous 1.69%
Shares
13 transactions
Others Institutions Holding LLY
# of Institutions
4,274Shares Held
757MCall Options Held
10.2MPut Options Held
11.4M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$89.2 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA74.2MShares$68.4 Billion1.03% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$60.6 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$47.2 Billion26.72% of portfolio
-
State Street Corp Boston, MA34.3MShares$31.6 Billion1.07% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $875B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...